Exchange: NASDAQ·Updated 07:30 PM EDT

VERX News

News
all
press releases
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAmgen maintains a massive, diversified portfolio of medicines serving approximately 17 million patients globally...
Nasdaq News: Markets
More News
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock
Key PointsVertex Pharmaceuticals' core business is rock-solid, but it is also slowly expanding into new areas...
Nasdaq News: Markets
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
Key PointsVertex Pharmaceuticals is slowly but surely expanding beyond its highly successful core therapeutic area...
Nasdaq News: Markets
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.32% on an annualized basis producing an average annual return of 14.56%. Currently, Vertex Pharmaceuticals has a marketread more...
Benzinga
Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?
Explore the exciting world of Vertex Pharmaceuticals (NASDAQ: VRTX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were...
Nasdaq News: Markets
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Key PointsVertex Pharmaceuticals' business could be in trouble if it faces competition in its core market...
Nasdaq News: Markets
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
Key PointsVertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area...
Nasdaq News: Markets
Vertex (VERX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Vertex (VRTX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
Key PointsVertex Pharmaceuticals could face competition in its most important market by far...
Nasdaq News: Markets

Advertisement|Remove ads.